We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00289640
Recruitment Status : Completed
First Posted : February 10, 2006
Last Update Posted : March 2, 2010
Information provided by:
Bristol-Myers Squibb